金威醫療(08143.HK)首季淨虧收窄35.68%至513.3萬港元
格隆匯 8 月 13日丨金威醫療(08143.HK)公佈截至2020年6月止首季業績,錄得收益982.6萬港元億港元,同比減少81.95%;毛利754.1萬港元,同比減少81.28%,毛利率約為76.75%;公司擁有人應占虧損513.3萬港元,同比收窄35.68%;基本每股虧損0.182港仙。
期內,來自一間綜合性醫院的營業額約為982.6萬港元(2019年:三間綜合性醫院約為5444.7萬港元),較去年同期減少約81.95%。該減少乃主要與出售嘉興市曙光醫療美容門診部及珠海九龍醫院有關。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.